Strike Pharma

Strike PharmaNOME2024-04-15T08:48:25+00:00

Strike Pharma

Strike Pharma are aiming to use their Adaptable Drug Affinity Conjugate (ADACTM) technology to enable development of individualized immunotherapeutic treatments based on the genetic profile of each patient’s tumor, to increase efficiency and decrease dosage level, ultimately reducing the risk of side effects.

Strike Pharma joined NOME in 2024.

Company details

Website

strikepharma.com

More companies

MetsystemNOME2024-04-15T10:43:58+00:00

Metsystem
Metsystem

Digital Health
Droplet IVNOME2024-04-15T08:52:38+00:00

Droplet IV
Droplet IV

Medical Devices
Strike PharmaNOME2024-04-15T08:48:25+00:00

Strike Pharma
Strike Pharma

Therapeutics
InossiaNOME2024-04-15T08:43:52+00:00

Inossia
Inossia

Medical Devices
Linio BiotechNOME2024-04-15T08:37:31+00:00

Linio Biotech
Linio Biotech

Medical Devices
BrainCaptureNOME2024-04-15T08:32:40+00:00

BrainCapture
BrainCapture

Digital Health
2N PharmaNOME2024-04-15T08:22:22+00:00

2N Pharma
2N Pharma

Other, Therapeutics
One-Carbon TherapeuticsNOME2024-04-15T08:21:33+00:00

One-Carbon Therapeutics
One-Carbon Therapeutics

Other, Therapeutics

VIEW ALL PROJECTS